News
2024
-
Press Release
-
Sysmex and J-TEC Sign a Basic Agreement to Advance Manufacturing Capabilities for Regenerative Medicine and Cell Therapy
-
Press Release
-
Sysmex’s HISCL™ TARC Assay Kit Becomes the First Serum Biomarker for the Diagnosis of Severe Drug Rashes to Receive Insurance Coverage in Japan
-
Press Release
-
Sysmex Acquires Naming Rights for Kobe’s Only Year-Round Ice Skating Rink
- The New Facility Will be Called as “Sysmex Kobe Ice Campus” -
-
Information
-
Sysmex Receives the Highest Rating of GOLD in the “Pride Index”, for Its Efforts Related to Sexual and Gender Minorities, for the Third Consecutive Year
-
Information
-
Sysmex Receives “Prize of the Director-General of the Kinki Bureau of Economy, Trade and Industry” and “Encouragement Prize for Invention” at Kinki Local Commendation for Inventions in 2024
-
Press Release
-
Summary of Consolidated Financial Results for the First Six Months (Semi-Annual Period) of the Fiscal Year Ending March 31, 2025 (PDF：315KB)
-
Press Release
-
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2024, and Notice of Revision to the Full-Year Financial Forecast (PDF：138KB)
-
Press Release
-
Sysmex Announces First Overseas Product Introduction and Clinical Use of the hinotori™ Surgical Robot System
- Accelerating Market Entry in Asia Pacific Region -
-
Information
-
Sysmex Group Promotes “PINKTOBER,” a Breast Cancer Awareness Campaign
-
Press Release
-
Sysmex Launches “HISCL™ HIT IgG Assay Kit” Contributing to the Detection of Adverse Reactions to Heparin Therapy
-
Press Release
-
Announcement of Executive Change (PDF：119KB)
-
Press Release
-
Sysmex Applies for Manufacturing and Marketing Approval of an Assay Kit to Predict the Risk of Adverse Reactions from Anti-amyloid β Antibody Drugs for Alzheimer’s Disease
- Determining the APOE Genotype from Genomic DNA in Blood -
-
Group Company News
-
Medicaroid Receives Regulatory Approval in Malaysia for the hinotori™ Surgical Robot System (Medicaroid)
-
Press Release
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025 (PDF：299KB)
-
Press Release
-
Sysmex Expands Strategic Alliance Agreement with QIAGEN in the Field of Genetic Testing
-
Press Release
-
Sysmex Group’s Largest Manufacturing Base Completed in India
-
Information
-
Sysmex Corporation Selected as a Constituent of All ESG Indices Adopted by the GPIF
-
Information
-
Sysmex Approved by the Science Based Targets initiative
-
Information
-
Sysmex Selected as One of the TIME’s World's Most Sustainable Companies of 2024
-
Press Release
-
Sysmex Begins Sales of Protein Assay Kits for Regenerative Cellular Medicine
- Automated Quality Control Testing of Cellular Therapeutics -
-
Press Release
-
Sysmex’s PA-100 AST System for Rapid Detection of Antimicrobial Susceptibility Wins One of the UK’s Biggest Science Prizes “Longitude Prize on AMR”
-
Press Release
-
Regarding an On-Site Inspection by the Japan Fair Trade Commission (PDF：144KB)
-
Information
-
Sysmex Receives the 11th Zero Malaria Award
- Contribution to Malaria Elimination through the Development and Dissemination of a New Malaria Diagnostic Device -
-
Press Release
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 (PDF：291KB)
-
Press Release
-
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2024 (PDF：251KB)
-
Press Release
-
Notice Regarding the Booking of a Loss on Valuation of Shares of Subsidiaries and Associates and a Provision for Loss on Guarantees (Non-Consolidated Financial Statements) (PDF：71KB)
-
Press Release
-
Announcement of Executive Change (PDF：158KB)
-
Group Company News
-
Medicaroid Receives MHLW Approval for the Use of the hinotori™ Surgical Robot System in Thoracic Surgery (Medicaroid)
-
Press Release
-
Sponsorship of the “Public-Private Partnership Project Invite Hyogo’s Students to EXPO 2025”
- Providing Opportunities for the Future-Leading Generations to Experience Unique Learning “Here” and “Now” - (PDF：309KB)
-
Information
-
Sysmex received an Award for Science and Technology (Development Category) in “the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology”
-
Press Release
-
Sysmex Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States and EU Countries
-
Press Release
-
Soluble Immune Checkpoint Factors in Blood as Potential Biomarkers of Therapeutic Efficacy for ICI Cancer Immunotherapy and Assessing T-cell Exhaustion (PDF：249KB)
-
Press Release
-
Sysmex Begins Sales of Six Testing Parameters for the Immunoassay Panel Related to Gynecological and Gonadal Hormones in Japan
- Contributing to the Diagnosis and Treatment of Gynecological Disorders and Infertility Treatment -
-
Information
-
Selected as a "Next Nadeshiko: Companies Supporting Dual-career and Co-parenting" in 2023, for creating an attractive workplace where everyone can work comfortably with peace of mind.
-
Information
-
Implementing the Group-wide Unified Social Contribution Activity, the “Sysmex Gives Back Campaign”
-
Press Release
-
Announcement of Organizational and Personnel Changes (PDF：242KB)
-
Press Release
-
Initiated In-house Production of HISCL™ TARC Assay Kit and HISCL™ ANP Assay Kit
- Succession of Manufacturing and Marketing Approval from Shionogi to Accelerate Global Expansion and Business Growth in the Immunochemistry Field -
-
Information
-
Educational Initiatives for the Next Generation - Implementing Health Education for Elementary School Students and SDG Education for Junior and Senior High School Students -
-
Information
-
【Conference presentation】Presenting the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases
-
Press Release
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024 (PDF：179KB)
-
Press Release
-
Notice Concerning Share Split and Partial Amendments to the Articles of Incorporation (PDF：232KB)
-
Information
-
Sysmex Selected for Inclusion in the Sustainability Yearbook 2024 by S&P Global
-
Press Release
-
Sysmex and Hitachi High-Tech Agree to Collaborate on Development of New Genetic Testing Systems
-
Press Release
-
Sysmex and CellaVision Expand Alliance with a View to Advancing Hematology Solutions
-
Press Release
-
Strengthening the Direct Sales and Service System for Business Expansion in Italy
-
Information
-
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Fifth Time
-
Information
-
Sysmex Corporate Introduction Movie Has Been Released
